Kira Poskanzer is a Founder-in-Residence at Arcadia Science, a biotech company transforming evolutionary innovations into therapeutic solutions. She also holds an appointment as an Associate Professor at the University of California, San Francisco (UCSF) in the Department of Biochemistry & Biophysics, where her lab studied circuit-level dynamics of astrocytes and neurons in the mammalian cerebral cortex using multi-photon imaging and electrophysiology. At Arcadia, Dr. Poskanzer is leading a translational group developing neuro-immune therapeutics based on molecules found in tick saliva. This early-stage venture aims to be Arcadia's first independent spin-out company. Dr. Poskanzer will talk about transitioning from academia to industry, working at an experimental research organization, balancing open and translational science, and building an early-stage startup. 

Arcadia Science Ticks as treasure troves